Ellington Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,620
Closed -$227K 682
2019
Q4
$227K Buy
+2,620
New +$215K 0.05% 405
2019
Q3
Sell
-2,725
Closed -$218K 714
2019
Q2
$218K Buy
+2,725
New +$209K 0.04% 460
2018
Q2
Sell
-20,331
Closed -$1.06M 710
2018
Q1
$1.06M Buy
+20,331
New +$1.1M 0.08% 178
2017
Q2
Sell
-24,628
Closed -$1.49M 805
2017
Q1
$1.49M Buy
+24,628
New +$1.49M 0.05% 32
2016
Q4
Sell
-7,650
Closed -$456K 712
2016
Q3
$456K Buy
+7,650
New +$447K 0.13% 306

Other funds holding MRK

Ellington Management Group's MRK Position: Q1 2020 in Review

Ellington Management Group sold out of Merck (MRK) in Q1 2020, closing a stake of 2,620 shares — an estimated $227K sold.

Ellington Management Group first reported a position in MRK in Q3 2016 and held it in 5 quarters. The position peaked at $1.49M in Q1 2017. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Ellington Management Group reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 2,620 Merck shares in Q1 2020, an estimated $227K.
  • Ellington Management Group first reported a position in Merck in Q3 2016 and held it in 5 quarters.
  • Ellington Management Group's Merck position peaked at $1.49M in Q1 2017.
  • 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.